{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:26:45Z","timestamp":1762835205519,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","idhjournal.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Disease &amp; Health"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.idh.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T15:30:44Z","timestamp":1685374244000},"page":"265-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time-to-first-isolation of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF): An underutilised metric in infection control?"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-5108","authenticated-orcid":false,"given":"John E.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline C.","family":"Rendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley C.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl_1","key":"10.1016\/j.idh.2023.05.002_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ofid\/ofw172.183","article-title":"Clinical characteristics of a military trauma cohort with Stenotrophomonas maltophilia infection","volume":"3","author":"Patterson","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idh.2023.05.002_bib2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.idh.2023.05.002_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2011.06.002","article-title":"Review: Staphylococcus aureus and MRSA in cystic fibrosis","volume":"10","author":"Goss","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.idh.2023.05.002_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1179\/1973947812Y.0000000024","article-title":"Predominance of hospital-associated MRSA among cystic fibrosis patients in a Turkish reference cystic fibrosis centre","volume":"24","author":"Yurdakul","year":"2012","journal-title":"J Chemother"},{"issue":"4","key":"10.1016\/j.idh.2023.05.002_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JCM.00255-09","article-title":"Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis","volume":"47","author":"Goodrich","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idh.2023.05.002_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcf.2018.04.008","article-title":"Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: result of a Belgian national survey","volume":"18","author":"Dod\u00e9mont","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.idh.2023.05.002_bib7","unstructured":"UK Cystic Fibrosis Registry 2020 Annual Data Report. Cystic Fibrosis Trust. Available at: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2021-\/CF_Annual%20Report%202020_V8.pdf [Last accessed 1 March 2023]."},{"key":"10.1016\/j.idh.2023.05.002_bib8","unstructured":"Cystic Fibrosis Foundation Patient Registry 2022 2021 Annual Data Report, Bethesda, Maryland. Available at: https:\/\/www.cff.org\/sites\/default\/files\/2021-11\/Patient-Registry-Annual-Data-Report.pdf. [Last accessed 1 March 2023]."},{"key":"10.1016\/j.idh.2023.05.002_bib9","unstructured":"Cystic Fibrosis Canada 2022. The Canadian Cystic Fibrosis Registry 2020 Annual Data Report. Toronto, Canada: Cystic Fibrosis Canada. Available at: https:\/\/www.cysticfibrosis.ca\/registry\/2020AnnualDataReport.pdf. [Last accessed 1 March 2023]."},{"key":"10.1016\/j.idh.2023.05.002_bib10","unstructured":"Methicillin-resistant Staphylococcus aureus (MRSA). Preventing Infections in Healthcare. Available at https:\/\/www.cdc.gov\/mrsa\/healthcare\/inpatient.html [Last accessed 5 May 2023]."},{"key":"10.1016\/j.idh.2023.05.002_bib11","unstructured":"The Society for Healthcare Epidemiology of America (SHEA). Compendium of strategies to prevent HAIs 2022 updates. Available at https:\/\/www.cambridge.org\/core\/journals\/infection-control-and-hospital-epidemiology\/compendium [Last accessed 5 May 2023]."},{"key":"10.1016\/j.idh.2023.05.002_bib12","unstructured":"Association for Professionals in Infection Control and Epidemiology (APIC). Available at http:\/\/apic.org\/Professional-Practice\/Practice-Resources\/[Last accessed 5 May 2023]."},{"issue":"1","key":"10.1016\/j.idh.2023.05.002_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guideline for cystic fibrosis: 2013 update","volume":"35","author":"Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Infection, Disease &amp; Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468045123000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468045123000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:15:31Z","timestamp":1762834531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468045123000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2468045123000330"],"URL":"https:\/\/doi.org\/10.1016\/j.idh.2023.05.002","relation":{},"ISSN":["2468-0451"],"issn-type":[{"type":"print","value":"2468-0451"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time-to-first-isolation of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF): An underutilised metric in infection control?","name":"articletitle","label":"Article Title"},{"value":"Infection, Disease & Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idh.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}